Moneycontrol PRO
HomeAuthorSandip das News

Sandip Das

Data Analyst

Bank of Maharashtra share price jumps 6% as Q1 profit spikes 25%

BUSINESS

Bank of Maharashtra share price jumps 6% as Q1 profit spikes 25%

Total income of the Bank increased to Rs 3,264.81 crore during April-June, 2020-21 from Rs 3,191.88 crore in the year-ago same period.

What changed for the market while you were sleeping? Top 10 things to know

BUSINESS

What changed for the market while you were sleeping? Top 10 things to know

Trends on SGX Nifty indicate a negative opening for the index in India with a 70 points loss.

Dilip Buildcon shares jump 8% on bagging Rs 4,167-crore order

BUSINESS

Dilip Buildcon shares jump 8% on bagging Rs 4,167-crore order

The stock was trading with volumes of 39,516 shares, compared to its five-day average of 17,628 shares, an increase of 124.16 percent.

ICICI Securities share price gains after June quarter profit jumps 70%

BUSINESS

ICICI Securities share price gains after June quarter profit jumps 70%

ICICI Securities' revenues surged 36 percent to Rs 546 crore in the June quarter from Rs 402 crore in the same period of the last financial year.

What changed for the market while you were sleeping? Top 10 things to know

BUSINESS

What changed for the market while you were sleeping? Top 10 things to know

Trends on SGX Nifty indicate a flat to positive opening for the index with a 14 points gain.

M&M Financial jumps 10% after stock turns ex-date for rights issue

BUSINESS

M&M Financial jumps 10% after stock turns ex-date for rights issue

The record date for the same is July 23, 2020. The rights issue will open on July 28 and close on August 11, 2020. The full amount of the issue price will be payable on application.

RIL hits fresh record high of Rs 2,010, m-cap tops Rs 12.7 lakh crore

BUSINESS

RIL hits fresh record high of Rs 2,010, m-cap tops Rs 12.7 lakh crore

Kotak Institutional Equities has a buy rating and has raised target to Rs 2,150 from Rs 1,750 while Nomura has a 'buy' recommendation and has raised the target price to Rs 2,200 from Rs 1,900.

IndiaMART InterMESH shares jump 12% after two-fold jump in Q1 profit

BUSINESS

IndiaMART InterMESH shares jump 12% after two-fold jump in Q1 profit

Revenue from operations of the company grew 3.9 percent to Rs 153.1 crore, primarily driven by marginal improvement in realisation of existing customers.

What changed for the market while you were sleeping? Top 10 things to know

BUSINESS

What changed for the market while you were sleeping? Top 10 things to know

Trends on SGX Nifty indicate a flat opening for the index in India with a 4 points loss.

D-Street Buzz: Oil & gas stocks gain led by BPCL; RIL, IOC, HPCL, ONGC add 2% each

BUSINESS

D-Street Buzz: Oil & gas stocks gain led by BPCL; RIL, IOC, HPCL, ONGC add 2% each

BPCL shares surged over 7 percent followed by Reliance Industries, Indian Oil Corporation and Hindustan Petroleum Corporation which added over 2 percent each.

Majesco share price hits upper circuit on board's nod to sell US subsidiary

BUSINESS

Majesco share price hits upper circuit on board's nod to sell US subsidiary

The Nasdaq-listed arm of the IT company will be sold at $13.1 apiece, a premium of around 74 percent to its closing price on July 17.

Bank of Maharashtra, BOI, IOB share prices rally 5-14% on reports of banking industry overhaul

BUSINESS

Bank of Maharashtra, BOI, IOB share prices rally 5-14% on reports of banking industry overhaul

The government plans to reduce the number of state-owned banks to five from 12.

What changed for the market while you were sleeping? Top 10 things to know

BUSINESS

What changed for the market while you were sleeping? Top 10 things to know

Trends on SGX Nifty indicate a gap up opening for the index in India with a 92 points gain.

D-Street Buzz: Pharma stocks trade mixed; Glenmark, Sun Pharma slip, Granules India edges higher

BUSINESS

D-Street Buzz: Pharma stocks trade mixed; Glenmark, Sun Pharma slip, Granules India edges higher

Glenmark Pharma was down over 3 percent followed by Sun Pharma, Lupin, Aurobindo Pharma, Cipla and Biocon.

Dhanuka Agritech stock price hits 52-week high on likely share buyback

BUSINESS

Dhanuka Agritech stock price hits 52-week high on likely share buyback

The stock price surged over 206 percent in the last 9 months and was trading at Rs 905, up Rs 91.55, or 11.25 percent. It has touched a 52-week high of Rs 935.

Telecom stocks end in the green after SC hearing on AGR case; RCom, Tata Teleservices jump 4% each

BUSINESS

Telecom stocks end in the green after SC hearing on AGR case; RCom, Tata Teleservices jump 4% each

Reliance Communications and Tata Teleservices jumped over 4 percent while Bharti Airtel and Vodafone Idea added a percent each.

What changed for the market while you were sleeping? Top 10 things to know

BUSINESS

What changed for the market while you were sleeping? Top 10 things to know

Trends on SGX Nifty indicate a negative opening for the index in India with a 48 points loss.

Granules India shares hit new high after Q1 profit jumps 34%

BUSINESS

Granules India shares hit new high after Q1 profit jumps 34%

The company's consolidated net profit rose 34 percent to Rs 111.4 crore against Rs 83.2 crore YoY. Its consolidated revenue went up 23.6 percent at Rs 735.6 crore against Rs 595.3 crore YoY.

D-Street Buzz: Metal stocks shine led by Hindustan Copper; Tata Steel, JSW Steel, SAIL gain 3% each

BUSINESS

D-Street Buzz: Metal stocks shine led by Hindustan Copper; Tata Steel, JSW Steel, SAIL gain 3% each

Hindustan Copper jumped over 7 percent followed by JSW Steel, SAIL, Tata Steel and MOIL which gained 3 percent each.

L&T Tech shares tumble after Q1 profit falls 42%

BUSINESS

L&T Tech shares tumble after Q1 profit falls 42%

L&T Technology reported 42.5 percent fall in consolidated net profit at Rs 117.3 crore for the first quarter ended June 30, 2020, as against Rs 203.9 crore in the same period last year.

Cadila Health shares gain as Zydus drug receives nod to conduct clinical trials to treat COVID-19

BUSINESS

Cadila Health shares gain as Zydus drug receives nod to conduct clinical trials to treat COVID-19

Zydus received approval from COFEPRIS to conduct clinical trials in Mexico with Pegylated Interferon alpha-2b to treat novel Coronavirus.

What changed for the market while you were sleeping? Top 10 things to know

BUSINESS

What changed for the market while you were sleeping? Top 10 things to know

Trends on SGX Nifty indicate a positive opening for the index in India with a 60 points gain.

IT index outperforms; Infosys jumps 12%; TCS, Mphasis gain, L&T Infotech hits all-time high

BUSINESS

IT index outperforms; Infosys jumps 12%; TCS, Mphasis gain, L&T Infotech hits all-time high

Among the sectors, the IT index jumped 5 percent led by heavyweight Infosys which surged 12 percent followed by L&T Infotech, Mphasis and TCS.

Titagarh Wagons shares up 3% after Matiere S.A.S becomes 100% wholly-owned subsidiary

BUSINESS

Titagarh Wagons shares up 3% after Matiere S.A.S becomes 100% wholly-owned subsidiary

The shareholding of the company in MTBPL has changed from 50 percent to 100 percent and thus MTBPL has become a wholly-owned subsidiary of the Company w.e.f. July 14, 2020, the company said.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347